JIBE 发表于 2025-3-23 13:03:27

http://reply.papertrans.cn/2/116/11573/11573-11.png

Ischemia 发表于 2025-3-23 16:12:23

http://reply.papertrans.cn/2/116/11573/11573-12.png

法律 发表于 2025-3-23 19:36:09

http://reply.papertrans.cn/2/116/11573/11573-13.png

兽群 发表于 2025-3-24 00:25:36

http://reply.papertrans.cn/2/116/11573/11573-14.png

crease 发表于 2025-3-24 06:14:19

http://reply.papertrans.cn/2/116/11573/11573-15.png

关心 发表于 2025-3-24 08:47:51

Submitted on: 22 September 2022.
Revised on: 16 January 2023.
Accepted on: 03 March 2023.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

Obstreperous 发表于 2025-3-24 14:30:52

Submitted on: 30 March 2001.
Revised on: 06 June 2001.
Accepted on: 23 July 2001.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

Minutes 发表于 2025-3-24 17:18:14

Submitted on: 30 November 2009.
Revised on: 21 February 2010.
Accepted on: 24 March 2010.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

横截,横断 发表于 2025-3-24 19:14:11

Submitted on: 25 February 2004.
Revised on: 07 May 2004.
Accepted on: 28 May 2004.

___________________HUMAN GENE THERAPY---MARY ANN LIEBERT, INC

Condescending 发表于 2025-3-24 23:22:53

http://reply.papertrans.cn/2/116/11573/11573-20.png
页: 1 [2] 3 4
查看完整版本: SCIE期刊HUMAN GENE THERAPY 2024/2025影响因子:3.988 (HUM GENE THER) (1043-0342). (MEDICINE, RESEARCH & EXPERIMENTAL)(医学、研究和实验)